Beranda › Gagal Jantung › South Dakota › Rapid City
Uji klinis Gagal Jantung di Rapid City, SD
8 studi untuk Gagal Jantung mencari peserta di lokasi sekitar Rapid City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Menerima pesertaFase 3
- Research Site, Rapid City
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Menerima pesertaFase 3
- Monument Health, Rapid City
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Menerima pesertaFase 3
- Research Site, Rapid City
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Menerima pesertaFase 3
- Monument Health Clinical Research, a department of Monument Health Rapid City Hospital, Inc., Rapid City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Menerima pesertaFase 3
- Monument Health Clinical Research, Rapid City
Alleviant ALLAY-HFrEF Study
Menerima peserta
- Monument Health, Rapid City
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Menerima pesertaFase 3
- Monument Health Clinical Rsrch, Rapid City
Alleviant ALLAY-HF Study
Menerima peserta
- Monument Health, Rapid City
Uji klinis Gagal Jantung di kota lain
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- Durham, NC26 studi
- St. Louis, MO26 studi
- Atlanta, GA25 studi
- Kansas City, MO25 studi
Studi lain di Rapid City
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.